| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.004 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.005 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.005 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.11 | 0.006 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.006 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.076 | 0.007 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.095 | 0.007 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.008 |